Are cytomegalovirus-negative kidney transplant recipients at an increased risk for malignancy after kidney transplantation?
CMV-negative patients that had a CMV-positive donor were found to have a higher risk of malignancy after kidney transplantation.
These findings suggest that A-FABP is an important contributor to both LPS-induced acute liver injury and diet-induced NAFLD by potentiating inflammation in Kupffer cells. Pharmacological inhibition of A-FABP may represent a promising modality for obesity-related non-alcoholic steatohepatitis.